MENU
OTLK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Outlook Therapeutics (OTLK) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

OTLK is expected to report earnings to rise 22.92% to -98 cents per share on May 15

Outlook Therapeutics OTLK Stock Earnings Reports
Q1'24
Est.
$-0.98
Q4'23
Beat
by $0.19
Q3'23
Missed
by $0.94
Q2'23
Missed
by $1.55
Q1'23
Missed
by $0.54
The last earnings report on February 14 showed earnings per share of -80 cents, beating the estimate of -99 cents. With 309.23K shares outstanding, the current market capitalization sits at 130.34M.
View a ticker or compare two or three
OTLK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
485 Route 1 South Building F
Phone
+1 609 619-3990
Employees
24
Web
https://www.outlooktherapeutics.com